pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Biotech is a pharma organization headquartered in TEL AVIV, DE. It trades on NYSE under ticker TEVA. Primary therapeutic focus areas include Asthma, Multiple Sclerosis, Pain, Crohn's Disease, Seasonal Allergic Rhini
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 473
- Drugs
- 447
- Patents
- 454
16 mg buprenorphine with 4 mg naloxone sublingual film
Approved · other · Evaluation of QTc Interval
16 mg buprenorphine with 4 mg naloxone sublingual film for Evaluation of QTc Interval is a Approved program (other) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code 71936002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Teva Pharma GmbH
- Phase
- Approved
- Modality
- other
- Indication
- Evaluation of QTc Interval
- Status
- terminated
- Trials
- 1